| The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ... Leukemia 36 (7), 1720-1748, 2022 | 2559 | 2022 |
| Expression of FoxP3, a key molecule in CD4+CD25+ regulatory T cells, in adult T‐cell leukaemia/lymphoma cells K Karube, K Ohshima, T Tsuchiya, T Yamaguchi, R Kawano, J Suzumiya, ... British journal of haematology 126 (1), 81-84, 2004 | 352 | 2004 |
| Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F K Shide, HK Shimoda, T Kumano, K Karube, T Kameda, K Takenaka, ... Leukemia 22 (1), 87-95, 2008 | 231 | 2008 |
| Genome‐wide array‐based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK‐cell leukemia and … Y Nakashima, H Tagawa, R Suzuki, S Karnan, K Karube, K Ohshima, ... Genes, Chromosomes and Cancer 44 (3), 247-255, 2005 | 222 | 2005 |
| Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001–2006 R Aoki, K Karube, Y Sugita, Y Nomura, K Shimizu, Y Kimura, ... Pathology international 58 (3), 174-182, 2008 | 221 | 2008 |
| CD10−MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features K Karube, Y Guo, J Suzumiya, Y Sugita, Y Nomura, K Yamamoto, ... Blood 109 (7), 3076-3079, 2007 | 212 | 2007 |
| Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses K Karube, M Nakagawa, S Tsuzuki, I Takeuchi, K Honma, Y Nakashima, ... Blood, The Journal of the American Society of Hematology 118 (12), 3195-3204, 2011 | 197 | 2011 |
| Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets K Karube, A Enjuanes, I Dlouhy, P Jares, D Martín-García, F Nadeu, ... Leukemia 32 (3), 675-684, 2018 | 196 | 2018 |
| IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis FA Scheeren, SA Diehl, LA Smit, T Beaumont, M Naspetti, RJ Bende, ... Blood, The Journal of the American Society of Hematology 111 (9), 4706-4715, 2008 | 178 | 2008 |
| Synergistic action of the microRNA‐17 polycistron and Myc in aggressive cancer development H Tagawa, K Karube, S Tsuzuki, K Ohshima, M Seto Cancer science 98 (9), 1482-1490, 2007 | 170 | 2007 |
| Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma A Oshiro, H Tagawa, K Ohshima, K Karube, N Uike, Y Tashiro, ... Blood 107 (11), 4500-4507, 2006 | 162 | 2006 |
| MYC alterations in diffuse large B-cell lymphomas K Karube, E Campo Seminars in hematology 52 (2), 97-106, 2015 | 148 | 2015 |
| Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells M Koyama, D Hashimoto, K Aoyama, K Matsuoka, K Karube, H Niiro, ... Blood, The Journal of the American Society of Hematology 113 (9), 2088-2095, 2009 | 139 | 2009 |
| Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa‐associated lymphoid tissue lymphoma T Kodama, K Ohshima, K Nomura, M Taniwaki, N Nakamura, S Nakamura, ... Histopathology 47 (5), 467-478, 2005 | 130 | 2005 |
| Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL T Tsuchiya, K Ohshima, K Karube, T Yamaguchi, H Suefuji, M Hamasaki, ... Blood 103 (1), 236-241, 2004 | 126 | 2004 |
| Genomic profiling for clinical decision making in lymphoid neoplasms L De Leval, AA Alizadeh, PL Bergsagel, E Campo, A Davies, A Dogan, ... Blood, The Journal of the American Society of Hematology 140 (21), 2193-2227, 2022 | 116 | 2022 |
| Low-grade follicular lymphoma with t (14; 18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 … Y Guo, K Karube, R Kawano, T Yamaguchi, J Suzumiya, GS Huang, ... Leukemia 19 (6), 1058-1063, 2005 | 114 | 2005 |
| Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T‐cell and NK‐cell lymphomas: analysis of 490 cases K Karube, R Aoki, Y Nomura, K Yamamoto, K Shimizu, S Yoshida, ... Pathology international 58 (2), 89-97, 2008 | 102 | 2008 |
| Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma CO Sung, SC Kim, S Karnan, K Karube, HJ Shin, DH Nam, YL Suh, ... Blood, The Journal of the American Society of Hematology 117 (4), 1291-1300, 2011 | 100 | 2011 |
| Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults K Suzuki, K Ohshima, K Karube, J Suzumiya, S Ohga, S Ishihara, ... International journal of oncology 24 (5), 1165-1174, 2004 | 94 | 2004 |
Kotaro ARITAUT MD Anderson Cancer CenterE-mailová adresa ověřena na: mdanderson.org